307. Canavan disease
[
3 clinical trials,
4 drugs（DrugBank:
0 drug),
0 target gene / 0 target pathway ]
Searched query = "Canavan disease"
The queries were searched in Public_title, Scientific_title, and Condition of the data. Export date: 11/20/2019. Trials are sorted by Date_enrolment from most recent to oldest in the table.
| No. | TrialID | Date_ enrollement | Last_Refreshed_ on | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00657748 | September 2009 | 4 May 2015 | Lithium and Acetate for Canavan Disease | Evaluation of the Tolerance and Efficiency of a Combined Oral Therapy With Lithium and GTA in Patients With Canavan Disease | Canavan Disease;Infantile;Deficiency Disease;Aspartoacylase;Leukodystrophy, Spongiform | Drug: Lithium Gluconate (drug) Glyceryl Triacetate GTA (drug) | Assistance Publique - Hôpitaux de Paris | European Leukodystrophy Association;European Leukodystrophy Association | Not recruiting | 1 Year | 15 Years | Both | 0 | Phase 2 | France |
| 2 | NCT00724802 | March 2008 | 19 February 2015 | Oral Glyceryl Triacetate (GTA) in Newborns With Canavan | Oral Glyceryl Triacetate (GTA) in Newborns With Canavan | Canavan Disease | Dietary Supplement: GTA (Glyceryl triacetate);Drug: GTA glyceryl triacetate | Shaare Zedek Medical Center | Recruiting | N/A | 18 Months | Both | 1 | N/A | Israel | |
| 3 | NCT00278707 | January 2006 | 19 February 2015 | GTA-Glyceryltriacetate for Canavan Disease | Phase 1 Treatment With GTA in Two Infant With Canavan Disease | Infantile Canavan Disease;Deficiency Disease, Aspartoacylase | Drug: GTA: Glyceryltriacetate | Sheba Medical Center | Not recruiting | N/A | 15 Months | Both | 5 | Phase 1 | Israel |